Spinal α2‐adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury
Open Access
- 1 May 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 148 (2), 233-244
- https://doi.org/10.1038/sj.bjp.0706731
Abstract
After partial nerve injury, the central analgesic effect of systemically administered gabapentin is mediated by both supraspinal and spinal actions. We further evaluate the mechanisms related to the supraspinally mediated analgesic actions of gabapentin involving the descending noradrenergic system. Intracerebroventricularly (i.c.v.) administered gabapentin (100 microg) decreased thermal and mechanical hypersensitivity in a murine chronic pain model that was prepared by partial ligation of the sciatic nerve. These effects were abolished by intrathecal (i.t.) injection of either yohimbine (3 microg) or idazoxan (3 microg), alpha(2)-adrenergic receptor antagonists. Pretreatment with atropine (0.3 mg kg(-1), i.p. or 0.1 microg, i.t.), a muscarinic receptor antagonist, completely suppressed the effect of i.c.v.-injected gabapentin on mechanical hypersensitivity, whereas its effect on thermal hypersensitivity remained unchanged. Similar effects were obtained with pirenzepine (0.1 microg, i.t.), a selective M(1)-muscarinic receptor antagonist, but not with methoctramine (0.1 and 0.3 microg, i.t.), a selective M(2)-muscarinic receptor antagonist. The cholinesterase inhibitor neostigmine (0.3 ng, i.t.) potentiated only the analgesic effect of i.c.v. gabapentin on mechanical hypersensitivity, confirming spinal acetylcholine release downstream of the supraspinal action of gabapentin. Moreover, the effect of i.c.v. gabapentin on mechanical but not thermal hypersensitivity was reduced by i.t. injection of L-NAME (3 microg) or L-NMMA (10 microg), both of which are nitric oxide (NO) synthase inhibitors. Systemically administered naloxone (10 mg kg(-1), i.p.), an opioid receptor antagonist, failed to suppress the analgesic actions of i.c.v. gabapentin, indicating that opioid receptors are not involved in activation of the descending noradrenergic system by gabapentin. Thus, the supraspinally mediated effect of gabapentin on mechanical hypersensitivity involves activation of spinal alpha(2)-adrenergic receptors followed by muscarinic receptors (most likely M(1)) and the NO cascade. In contrast, the effect of supraspinal gabapentin on thermal hypersensitivity is independent of the spinal cholinergic-NO system.Keywords
This publication has 64 references indexed in Scilit:
- Role of descending noradrenergic system and spinal α2‐adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouseBritish Journal of Pharmacology, 2005
- Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channelsNeuropharmacology, 2004
- Central sensitization and LTP: do pain and memory share similar mechanisms?Trends in Neurosciences, 2003
- Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the ratRegional Anesthesia & Pain Medicine, 1997
- Gabapentin (neurontin) and S‐(+)‐3‐isobutylgaba represent a novel class of selective antihyperalgesic agentsBritish Journal of Pharmacology, 1997
- Analgesic Doses of Intrathecal but Not Intravenous Clonidine Increase Acetylcholine in Cerebrospinal Fluid in HumansAnesthesia & Analgesia, 1997
- Analgesic Doses of Intrathecal but Not Intravenous Clonidine Increase Acetylcholine in Cerebrospinal Fluid in HumansAnesthesia & Analgesia, 1997
- The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium ChannelJournal of Biological Chemistry, 1996
- Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesiaBrain Research, 1987
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980